Troya Therapeutics, a recent spin-off from the Department of Molecular Biology and Genetics at Aarhus University, aims to mitigate cancer treatment side effects via immunotherapy. Their technology enhances current treatments, paving the way for novel drugs across multiple therapies.
Established in 2023.
